Bridgeway Capital Management’s Sensei Biotherapeutics SNSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,395
| Closed | -$23.5K | – | 1244 |
|
|
2024
Q4 | $23.5K | Hold |
2,395
| – | – | ﹤0.01% | 1181 |
|
|
2024
Q3 | $28.6K | Sell |
2,395
-1,500
| -39% | -$17.9K | ﹤0.01% | 1239 |
|
|
2024
Q2 | $48.3K | Sell |
3,895
-1,750
| -31% | -$21.7K | ﹤0.01% | 1225 |
|
|
2024
Q1 | $119K | Hold |
5,645
| – | – | ﹤0.01% | 1187 |
|
|
2023
Q4 | $78.1K | Hold |
5,645
| – | – | ﹤0.01% | 1276 |
|
|
2023
Q3 | $84.7K | Hold |
5,645
| – | – | ﹤0.01% | 1251 |
|
|
2023
Q2 | $129K | Hold |
5,645
| – | – | ﹤0.01% | 1217 |
|
|
2023
Q1 | $169K | Hold |
5,645
| – | – | ﹤0.01% | 1131 |
|
|
2022
Q4 | $168K | Sell |
5,645
-2,500
| -31% | -$74.5K | ﹤0.01% | 1128 |
|
|
2022
Q3 | $252K | Buy |
8,145
+6,250
| +330% | +$193K | 0.01% | 1089 |
|
|
2022
Q2 | $86K | Hold |
1,895
| – | – | ﹤0.01% | 1245 |
|
|
2022
Q1 | $88K | Buy |
+1,895
| New | +$88K | ﹤0.01% | 1266 |
|